Jeffrey Ubben‘s ValueAct Holdings, LP has released its quarterly 13F report. In this article, we will quickly review the fund’s latest biggest holdings and a comparison on its previous holdings. Microsoft Corporation (NASDAQ:MSFT), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Motorola Solutions Inc (NYSE:MSI) are the biggest positions in ValueAct Holdings.

Microsoft, is MSFT a good stock to buy, Mojang AB, acquisition, Minecraft, Anurag Rana,

Microsoft Corporation (NASDAQ:MSFT) is one of the biggest position in ValueAct Capital this quarter. It has 74,237,469 shares of the technology giant worth 3,441 million. In the last 13F quarterly report of the fund, it had 74,236,642 shares of MSFT worth $3095 million. This means that the fund has increased its holding on the tech stock. William Duhamel’s Route One Investment Company is one of the biggest shareholders of Microsoft Corporation (NASDAQ:MSFT). The company reported its last sales back in October when 3,200,000 of its shares were sold at around $46 price per share.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is the second biggest position in ValueAct Capital. The fund has 18,923,877 shares of the company worth $2482 million. Last quarter, the fund had 18,923,877 shares of the company worth $2386 million. Glenn Greenberg’s Brave Warrior Capital is one of the biggest shareholders of Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The company reported its last sales June this year when 10,203 of its shares were sold at $121 per share price.

Motorola Solutions Inc (NYSE:MSI) is the third biggest position in ValueAct Capital. The fund has 28,907,623 shares of the company worth $1829 million. The fund had 28,907,623 shares of Motorola Solutions Inc (NYSE:MSI) worth $1924. John Shapiro’s Cheiftain Capital is one of the biggest shareholders of Motorola Solutions Inc (NYSE:MSI). The company reported its last sales this month when 1,000 of its shares were sold at $66 per share price.

Suggested Articles:

Countries With Highest Gas Prices

Best Selling Pharmaceutical Drugs

Share.